Multi-omics Study in Citrin Deficiency
Launched by JOHANNES HAEBERLE · Mar 19, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding Citrin Deficiency (CD), a condition that affects how the body processes certain nutrients. CD can cause a range of symptoms and has different forms, some of which are more severe. Currently, there is no cure for CD, and patients usually manage their symptoms through dietary changes and regular visits to their doctors. One of the biggest challenges in finding better treatments is that we lack reliable tests (called biomarkers) that can show how severe the condition is or how well treatments are working. This study aims to find these important biomarkers by analyzing blood samples from patients with Citrin Deficiency.
The trial is currently looking for participants, including anyone diagnosed with Citrin Deficiency, regardless of age or gender. If you or someone you know has been diagnosed with this condition, you may be eligible to join the study. Participants will provide blood samples, which will help researchers learn more about the condition and potentially lead to better treatments in the future. It's an important step towards improving care for people with Citrin Deficiency.
Gender
ALL
Eligibility criteria
- Inclusion Criteria for patient group:
- • confirmed diagnosis of citrin deficiency
- Exclusion Criteria for control group:
- • any metabolic disease
About Johannes Haeberle
Johannes Haeberle is a dedicated clinical trial sponsor committed to advancing medical research and innovation. With a focus on delivering high-quality clinical trials, Haeberle emphasizes rigorous adherence to regulatory standards and ethical guidelines. The organization collaborates with a network of esteemed research institutions and healthcare professionals to facilitate the development of novel therapies and improve patient outcomes. Through a comprehensive approach to trial design, execution, and monitoring, Johannes Haeberle aims to contribute significantly to the advancement of medical science and enhance the understanding of various health conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
Bristol, , United Kingdom
Taipei, , Taiwan
Kumamoto, , Japan
London, , United Kingdom
Salford, , United Kingdom
London, , United Kingdom
Birmingham, , United Kingdom
Matsumoto, Nagano, Japan
Sheffield, , United Kingdom
Chiba, , Japan
Kurume Shi, Fukuoka, Japan
Gyeongsangnam Do, , Korea, Republic Of
Saitama, Iruma, Japan
Yokohama, Kanagawa, Japan
Tokyo, Minato City, Japan
Sendai, Miyagi, Japan
Hokkaido, Sapporo, Japan
Osaka, Umeda, Japan
Yamagata City, , Japan
Taipei, , Taiwan
Manchester, Lancashire, United Kingdom
Birmingham, , United Kingdom
Yangsang, Gyeongsang, Korea, Republic Of
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported